Welcome to our dedicated page for Nature’S Sun SEC filings (Ticker: NATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nature’s Sunshine Products, Inc. filings document the public-company record for a Nasdaq-listed Utah corporation that manufactures and markets herbal and nutritional supplements and personal care products. Form 8-K reports furnish operating and financial results, non-GAAP reconciliations, material-event disclosures, executive appointments, compensatory arrangements, material agreements and capital-structure updates for NATR common stock.
Proxy materials cover board elections, governance practices, executive compensation, equity awards, pay-versus-performance disclosure and shareholder voting matters. The filing record also addresses risk, regulatory and business disclosures related to the company’s global wellness product operations and distribution markets.
Natures Sunshine Products EVP & President, Europe Bryant J. Yates reported compensation-related share activity in Common Shares. On March 6, he received 7,761 restricted stock units (RSUs) at a reference price of $25.06 per share, which will vest in three equal annual installments through March 6, 2029. He also acquired 1,317 vested shares tied to achieving an adjusted EBITDA milestone of $48M over a rolling 12‑month period under a March 11, 2024 performance-based RSU grant. To cover taxes upon vesting, 450 shares were withheld at $25.06 per share, a non‑market tax-withholding disposition. After these transactions, Yates directly holds 107,232 Common Shares.
Romanzi Kenneth G. reported acquisition or exercise transactions in this Form 4 filing.
NATURES SUNSHINE PRODUCTS INC reported that Chief Executive Officer Kenneth G. Romanzi received a grant of 29,928 common-share-equivalent restricted stock units at a reference price of $25.06 per share. Following this award, he directly holds 132,809 common shares.
The RSUs were granted under his employment agreement dated October 10, 2025 and vest in three equal annual installments from the initial grant date through March 6, 2029, with each RSU representing the right to receive one NATR common share.
Fritz Erich A reported acquisition or exercise transactions in this Form 4 filing.
Natures Sunshine Products executive Fritz Erich, EVP of Global Supply Chain, received a grant of 8,180 common shares in the form of restricted stock units at a reference price of $25.06 per share. Each RSU represents one share of common stock and vests in three equal annual installments through March 6, 2029. Following this compensation grant, Erich directly holds 18,940 common shares, reflecting his ongoing equity stake in the company.
Fuller Kevin Gregory reported acquisition or exercise transactions in this Form 4 filing.
NATURES SUNSHINE PRODUCTS INC granted Global Chief Marketing Officer Kevin Gregory Fuller 7,965 common shares in the form of restricted stock units at an indicated value of $25.06 per share. The RSUs vest in three equal annual installments from the initial grant date through March 6, 2029, bringing his direct holdings to 30,922 shares.
Nature’s Sunshine Products reported record 2025 results with strong growth in sales and profitability. Full-year net sales rose 5.7% to $480.1 million, while GAAP net income attributable to common shareholders increased to $19.5 million, or $1.06 per diluted share, from $7.7 million, or $0.40 per diluted share. Adjusted EBITDA grew 21.7% to $49.4 million.
Fourth-quarter net sales rose 4.7% to $123.8 million and GAAP EPS improved to $0.23 from a loss of $(0.02). Q4 adjusted EBITDA increased 16% to $11.9 million. Growth was driven by stronger digital channels and solid performance in North America and key international markets, alongside higher gross margins.
The company ended 2025 with $93.9 million in cash and cash equivalents and no outstanding debt, after repurchasing 1,260,000 shares for $16.3 million. For 2026, it projects net sales between $500 million and $515 million and adjusted EBITDA between $50 million and $54 million. The filing also notes modest base salary increases for the CFO and Executive Vice President, Asia.
Natures Sunshine Products Inc executive Nathan Brower, EVP and General Counsel, reported an in-kind charitable donation of 1,500 common shares of company stock.
The shares were transferred on November 24, 2025 at a reported price of $20.56 per share, the volume-weighted average price that day, and he now holds 45,235 shares directly. The donation was made for charitable purposes and no consideration was received.
Natures Sunshine Products executive Bryant J. Yates reported a disposition of 1,700 common shares on December 12, 2025 at $22.29 per share. After this transaction, he directly owns 98,604 common shares of the company. Yates is listed as Executive Vice President and President, Europe, and the report covers a transaction by a single reporting person.
Nature's Sunshine Products (NATR) executive Daniel C. Norman, EVP & President, Asia, reported two transactions in company common shares. On 11/12/2025, he sold 8,884 common shares at a weighted average price of $20.46 per share, with individual trades ranging from $20.08 to $21.20. On 11/17/2025, he transferred 3,571 common shares as an in-kind charitable donation, for which no consideration was received; the stated price of $20.79 per share reflects the volume-weighted average trading price that day. After these transactions, he beneficially owned 63,065 common shares directly.
Natures Sunshine Products, Inc. (NATR) reported an insider stock transaction by its Senior Vice President and Chief Accounting Officer, Jonathan D. Lanoy. On 11/18/2025, he sold 5,000 common shares of NATR in an open-market transaction coded "S" for sale at a price of $20.45 per share. After this transaction, he beneficially owned 46,233 common shares, held directly. The filing was made on Form 4, which is used to disclose changes in ownership by company insiders.